• Leahy, making sure that the government does not have to disclose any information under the Freedom of Information Act relating to drug inspections from a foreign government agency;

• Sen. Rob PortmanRob PortmanGOP debates going big on tax reform Who is Tim Ryan? A closer look at Pelosi’s challenger Battle for the Senate: Top of ticket dominates MORE (R-Ohio), directing the attorney general to establish uniform standards for the exchange of controlled substance and prescription information for the purpose of preventing diversion, fraud and abuse of controlled substances and other prescription drugs; and,

• Sen. Tom CoburnTom CoburnWill Trump back women’s museum? Don't roll back ban on earmarks Ryan calls out GOP in anti-poverty fight MORE (R-Okla.), to require an independent assessment of the FDA's review of drug applications.

ADVERTISEMENT
Also by unanimous consent, the Senate approved an amendment from Portman to place synthetic drugs on Schedule I of the Controlled Substances Act.

Harkin also announced that another amendment from Coburn would be withdrawn — a proposal to require the Health and Human Services secretary to ensure that performance awards are connected to employee evaluations.

Senate Majority Leader Harry ReidHarry ReidLawmakers eye early exit from Washington McCain to support waiver for Mattis, Trump team says Reeling Dems look for new leader MORE (D-Nev.) said Thursday morning that he hoped some of the remaining 11 amendments to the FDA bill could be handled quickly. With the four unanimous consent votes, seven roll-call votes remain before final passage. These votes are scheduled for 2 p.m., but Reid said he hoped they might start earlier.